Eden Research Plc commercial partner receives full authorisation for Cedroz in Mexico

December 19, 2019 09:02 AM GMT
Team Kalkine

Eden Research Plc (LON: EDEN) has announced that its commercial partner, Eastman Chemical Company, has received full authorisation for Eden's nematicide formulation, marketed as Cedrozâ¢ by Eastman, in Mexico.

The company has reported that with this authorisation access has now been gained into the all-important US agricultural import market. It is first for the companyâs developed products in Mexico, giving it a foothold into the Americas.
Cedroz an innovative and natural solution, offers growers huge benefits by offering high levels of efficacy against nematodes.
On 19^th December 2019, at the time of writing, GMT 08:03 AM, EDEN shares were trading at GBX 8.75, up by 0.95 points or 12.18% against the previous day closing price.

Tags:

LSE: EDEN

Disclaimer

The website https://kalkinemedia.com/uk is a service of Kalkine Media Ltd (Kalkine Media), Company Number 12643132. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.